Vimarsana
Biggest News Aggregation in the World

Page 25 - Director John News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Director John. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Director John Today - Breaking & Trending Today

Cytokinetics (NASDAQ:CYTK) Price Target Cut to $70.00 - Vimarsana News

Cytokinetics (NASDAQ:CYTK) Price Target Cut to $70.00

Cytokinetics (NASDAQ:CYTK – Free Report) had its price objective decreased by Raymond James from $92.00 to $70.00 in a research note released on Thursday, Benzinga reports. Raymond James currently has an outperform rating on the biopharmaceutical company’s stock. Other analysts have also recently issued reports about the company. Truist Financial reissued a buy rating and […]

Needham & Company LLC Trims Cytokinetics (NASDAQ:CYTK) Target Price to $72.00 - Vimarsana News

Needham & Company LLC Trims Cytokinetics (NASDAQ:CYTK) Target Price to $72.00

Cytokinetics (NASDAQ:CYTK – Free Report) had its price objective cut by Needham & Company LLC from $108.00 to $72.00 in a report released on Thursday morning, Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. Other analysts also recently issued reports about the company. JMP Securities reduced their price objective on […]

Cytokinetics (NASDAQ:CYTK) Given New $72.00 Price Target at Needham & Company LLC - Vimarsana News

Cytokinetics (NASDAQ:CYTK) Given New $72.00 Price Target at Needham & Company LLC

Cytokinetics (NASDAQ:CYTK – Free Report) had its price target reduced by Needham & Company LLC from $108.00 to $72.00 in a research report report published on Thursday morning, Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. A number of other analysts have also recently issued reports on CYTK. Mizuho reduced […]

HC Wainwright Trims Cytokinetics (NASDAQ:CYTK) Target Price to $90.00 - Vimarsana News

HC Wainwright Trims Cytokinetics (NASDAQ:CYTK) Target Price to $90.00

Cytokinetics (NASDAQ:CYTK – Free Report) had its price target lowered by HC Wainwright from $94.00 to $90.00 in a report released on Thursday, Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. CYTK has been the topic of several other research reports. JMP Securities reduced their price target on shares […]

Bank of America Cuts Cytokinetics (NASDAQ:CYTK) Price Target to $60.00 - Vimarsana News

Bank of America Cuts Cytokinetics (NASDAQ:CYTK) Price Target to $60.00

Cytokinetics (NASDAQ:CYTK – Free Report) had its price target lowered by Bank of America from $70.00 to $60.00 in a research report report published on Thursday, Benzinga reports. The firm currently has a neutral rating on the biopharmaceutical company’s stock. Other equities research analysts have also issued reports about the company. Barclays decreased their target […]